Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Colgate Maximum Cavity Protection** is an over-the-counter anticaries fluoride toothpaste developed and manufactured by Colgate-Palmolive. In the United States product presentation associated with the clinical-trial context, the active anticaries ingredient is **sodium monofluorophosphate 0.76%**, equivalent to 0.15% fluoride ion. During brushing, fluoride promotes remineralization of early enamel mineral loss and increases enamel resistance to acid-mediated demineralization, helping prevent dental caries. The name is also used internationally for related toothpaste products whose fluoride systems and excipient compositions may differ by market; this annotation reflects the sodium-monofluorophosphate Colgate Cavity Protection formulation associated with the provided trial context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colgate Maximum Cavity Protection.